Australian university to beef up Chagas' research

08/15/2008 | Australian Life Scientist

Australia's Murdoch University and Epichem, a partnering medicinal chemistry company, received $3 million from the Drugs for Neglected Diseases Initiative, a global, collaborative nonprofit, to boost its Chagas' disease research program. The university's Parasitology Research Group will lead the research and will be the only center in the southern hemisphere screening drugs against the major diseases transmitted through vectors.

View Full Article in:

Australian Life Scientist

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY